HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy

Genome sequencing has uncovered an array of recurring somatic mutations in different non-Hodgkin lymphoma (NHL) subtypes. If affecting protein-coding regions, such mutations may yield mutation-derived peptides that may be presented by HLA class I proteins and recognized by cytotoxic T cells. A recur...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelde, Annika, Walz, Juliane Sarah, Kowalewski, Daniel Johannes, Schuster, Heiko, Wolz, Olaf-Oliver, Peper, Janet Kerstin, Cardona Gloria, Yamel, Langerak, Anton W., Muggen, Alice F., Claus, Rainer, Bonzheim, Irina, Fend, Falko, Salih, Helmut Rainer, Kanz, Lothar, Rammensee, Hans-Georg, Stevanović, Stefan, Weber, Alexander N. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384368/
https://www.ncbi.nlm.nih.gov/pubmed/28405493
http://dx.doi.org/10.1080/2162402X.2016.1219825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384368/
https://www.ncbi.nlm.nih.gov/pubmed/28405493
http://dx.doi.org/10.1080/2162402X.2016.1219825

Ejemplares similares